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Abstract
Background: Brucella melitensis is the most important pathogenic species of Brucella spp. which affects goats and
sheep and causes caprine and ovine brucellosis, respectively. Serological tests for diagnosis of brucellosis such as Rose
Bengal plate test (RBPT) and enzyme-linked immunosorbent assay (ELISA) usually utilize smooth lipopolysaccharides
(S-LPS) as a diagnostic antigen which could give false positive serological reactions. Outer membrane proteins (OMP)
of B. melitensis have been used as alternative diagnostic antigens rather than S-LPS for differential serological diagnosis
of brucellosis, mainly in ELISA with single recombinant OMP (rOMP) as a diagnostic antigen. Nevertheless, the use of
single format mainly showed lack of sensitivity against the desired rOMP. Therefore, this study aimed to determine
whether a newly developed rOMPs indirect ELISA (rOMPs I-ELISA), based on combination of rOMP25, rOMP28 and
rOMP31of B. melitensis, has a potential benefit for use in the serodiagnosis of brucellosis.
Methods: In this study, omp25, omp28 and omp31 of B. melitensis were cloned and expressed using prokaryotic pET-32
Ek/LIC system and their respective rOMPs were combined as one coating antigen to develop rOMPs I-ELISA. Three
groups of BALB/c mice were used to elicit antibody response. Group 1, infected with B. melitensis strain 0331 field
strain; group 2, injected with B. melitensis Rev.1 vaccine strain and group 3, infected with Yersinia enterocolitica O:9.
Antibody responses in three groups of mice were investigated using Rose Bengal plate test (RBPT) and rOMPs I-ELISA.
Results: The production of rOMP25, rOMP28 and rOMP31 of B. melitensis were achieved and Western immunoblotting
analysis demonstrated their reactivity. The RBPT was unable to differentiate the vaccinated mice (group 2) and mice
infected with Y. enterocolitica O:9 (group 3) and categorized them wrongly as positive for brucellosis. In contrast, the
rOMPs I-ELISA was able to differentiate the mice infected with B. melitensis strain 0331 (group 1) from both of group 2
and group 3, and recorded 100% sensitivity and 100% specificity.
Conclusions: The results of this study suggested that rOMPs of B. melitensis has potential diagnostic ability to
differentiate the FPSR in serological diagnosis of brucellosis.
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Background
Brucellosis is one of the most important bacterial zoo-
noses worldwide [1]. Brucella melitensis is the main etio-
logical agent of sheep and goats, and human brucellosis
[2]. In control programs of brucellosis, practical solu-
tions for diagnosis of the disease require inexpensive,
simple, rapid and specific test to identify the infected an-
imals [3]. Therefore, an indirect diagnosis approach of
brucellosis using serological methods mainly Rose Bengal
plate test (RBPT), complement fixation test (CFT) and
enzyme-linked immunosorbent assay (ELISA) are recom-
mended for large-scale surveillance and/or eradication
purposes [4]. These tests usually use S-LPS, part of S-
LPS or whole cells as an antigen to detect antibodies to
smooth Brucella spp. which could give false positive
serological reactions (FPSR) results due to difficulties to
differentiate between animals vaccinated with B. melitensis
Rev.1 strain and infected animals [5–7]. Another reason
which can lead to FPSR is cross-reactivity with other
Gram-negative bacteria like Yersinia enterocolitica O:9,
Salmonella spp. and Escherichia coli [2, 8, 9].
The outer membrane proteins (OMP) of Brucella spp.
were found to be attractive alternative antigens rather
than S-LPS for serological diagnosis to minimize the
FPSR [10]. Brucella OMPs are grouped according to
their apparent molecular weights as group 1 (94 or
88 kDa), group 2 (36–38 kDa), and group 3 (25–27 and
31–34 kDa). Group 1 was identified as minor whereas
group 2 and 3 OMPs were identified as major OMPs
[11]. Group 3 major OMPs have been approved to be
useful for the differentiation of antibody responses be-
tween naturally infected animals and Rev.1 vaccinated
animals [12, 13]. Two genes were identified for the
group 3 proteins of Brucella and were named omp25
and omp31, coding for 25–27 and 31–34 kDa major
OMPs, respectively [14, 15]. In addition, OMP28 of B.
melitensis has been identified as another member of
group 3 OMPs which is coded by omp28 gene [16].
Others reported that OMP28 is a cytosoluble 28 kDa
protein (CP28) which is localized in the periplasm [13],
or 26 kDa periplasmic protein (BP26) which is coded by
bp26 gene [17]. Several individual omp genes have been
cloned and their expressed proteins were tested in
immunoenzymatic assays for serodiagnosis of brucellosis
in animals like recombinant OMP25 [18], recombinant
OMP28 [19] and recombinant OMP31 [20]. However,
lack of sensitivity to detect antibodies against the desired
rOMP was the main obstacle facing these recombinant
proteins. For that reason, combination of more than one
recombinant protein in a single immunoenzymatic test
could increase the sensitivity [21].
Small laboratory animals are frequently employed as
models in brucellosis research [22]. Among them,
BALB/c mice, has been extensively used in brucellosis
research for many years mainly due to economic and
practical reasons [22–24]. In addition the well-known
biology of this murine species, especially the humoral
and cellular immunity, makes it the ideal model for bru-
cellosis research [22].
Accordingly, this study aimed to describe the expres-
sion and purification of three recombinant proteins,
rOMP25, rOMP28 and rOMP31, of B. melitensis using
E. coli expression system. The produced recombinant
proteins were combined and used as one coating antigen
in an indirect ELISA (I-ELISA) to evaluate its differential
serodiagnosis using mouse mode.
Results
Construction of pET-32 Ek/LIC-omp cloning vector
Using polymerase chain reaction (PCR), the omp25,
omp28 and omp31 gene were amplified from the chromo-
somal DNA of B. melitensis strain 0331 using gene specific
primers and produced the expected product sizes of 668,
779 and 749 bp for omp25, omp28 and omp31 respectively
(Fig. 1).
Nucleotide sequence of omp25, omp28 and omp31
Nucleotide sequence analysis of pET-32 Ek/LIC-omp25,
pET-32 Ek/LIC-omp28 and pET-32 Ek/LIC-omp31 in-
serts revealed the presence of open reading frame (ORF)
of 642, 753 and 723 nucleotides for the three genes re-
spectively. The sequences of omp25, omp28 and omp31
were deposited in the Genbank and assigned the accession
numbers [GenBank: JX627633], [GenBank: JX627634] and
[GenBank: JX627635] respectively.
Fig. 1 Agarose gel electrophoresis of PCR products of omp genes of
B. melitensis strain 0331. Using gene specific primers that include the
indicated 5′ LIC extensions, producing expected bands. Lane M,
100 bp DNA ladder (New England Biolabs, USA); lane 1, omp25 with
product size 668 bp; lane 2, omp28 with product size 779 bp; lane 3,
omp31 with product size 749 bp; lane 4, negative control
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SDS-PAGE analysis and immunoreativity of recombinant
fusion proteins
The majority of the expressed rOMP25, OMP28 and
OMP31 were found in the soluble fraction. Therefore,
the expressed proteins were extracted and purified under
native conditions. Approximately final concentration of
50 μg/ml purified recombinant protein could be achieved.
The SDS-PAGE analysis showed the presence of the ex-
pected 42 k, 45 kDa and Da 48 kDa of purified recombin-
ant fusion proteins (Figs. 2, 3 and 4). The results of
Western immunoblot analysis revealed the immunoreac-
tivity of purified rOMP25, OMP28 and OMP31 with the
three types of antibodies; two types of monoclonal anti-
bodies (His.Tag and S.Tag HRP conjugated monoclonal
antibodies), in addition to rabbit polyclonal antibodies
against B. melitensis strain 0331 (Figs. 5, 6 and 7).
Rose Bengal plate test
The RBPT gave positive results for the tested sera of the
three groups of mice, and it was unable to differentiate
the antibody response among these groups. However, the
RBPT results showed that the mice in group 1 (n = 45)
were able to elicit high titers of anti-Brucella antibodies
due to infection with Brucella melitensis strain 0331 and
peaked 1100 IU/ml at day 42. While, the mice in group
2 (n = 45) were able to elicit lower titers of antibodies
due to vaccination with B. melitensis Rev.1 strain, and
peaked 900 IU/ml at day 49. No significant differences
(p > 0.05) were found between group 1 and group 2 and
this due to inability of RBPT to differentiate between
the mice vaccinated with B. melitensis Rev.1 strain and
those infected with B. melitensis strain 0331. Although
the mice in group 3 (n = 45) developed too low titers of
antibodies due to infection with Y. enterocolitica O:9
(peaked 100 IU/ml at day 42), the RBPT was able to de-
tect these cross reacting antibodies (Fig. 8).
Fig. 2 Analysis by SDS–PAGE of rOMP25 fusion protein. Lane M,
Protein Marker; lane 1, soluble cell proteins of E. coli BL21(DE3) cells
with recombinant omp25 before induction; lane 2, soluble cell proteins
of E. coli BL21(DE3) cells with recombinant omp25 after autoinduction;
lane 3, rOMP25 fusion protein (arrow) purified by affinity purification
Fig. 3 Analysis by SDS–PAGE of rOMP28 fusion protein. Lane M,
Protein Marker; lane 1, soluble cell proteins of E. coli BL21(DE3) cells
with recombinant omp28 before induction; lane 2, soluble cell proteins
of E. coli BL21(DE3) cells with recombinant omp28 after autoinduction;
lane 3, rOMP28 fusion protein (arrow) purified by affinity purification
Fig. 4 Analysis by SDS–PAGE of rOMP31 fusion protein. Lane M,
Protein Marker; lane 1, soluble cell proteins of E. coli BL21(DE3) cells
with recombinant omp31 before induction; lane 2, soluble cell proteins
of E. coli BL21(DE3) cells with recombinant omp31 after autoinduction;
lane 3, rOMP31 fusion protein (arrow) purified by affinity purification
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Recombinant OMPs I-ELISA
All mice sera in three groups of mice and negative control
were tested by I-ELISA using rOMPs as coating antigen.
Using the receiver operating characteristics (ROC), a cut-
off value of the positivity percent (PP) ≥ 43.30 was consid-
ered positive for brucellosis by rOMPs I-ELISA. The
rOMPs I-ELISA results showed that antibodies against
rOMPs was elicited as early as day 7 (PP = 49.5) and reach
the peak at day 56 (PP = 95.5) in group1. While low anti-
body titers were detected in both group 2 and group 3
and recorded (PP = 25.3 and 13.2) at day 7, and (PP = 33.2
and 29.7) at day 56, respectively (Fig. 9). Tukey’s test ana-
lysis of PP values indicated the presence of significant
difference (p < 0.05) between group 1 and each of group
2 and group 3. Moreover, by testing sera from mice in-
fected with B. melitensis strain 0331, the results of
Fig. 5 Western immunoblot analysis of purified rOMP25 fusion protein. Lane M, Precision Plus Protein All Blue Standards (Bio-Rad, USA); lane 1,
purified rOMP25 detected using His.Tag monoclonal antibody; lane 2, purified rOMP25 detected using S.Tag monoclonal antibody; lane 3, purified
rOMP25 detected using rabbit polyclonal antibodies against B. melitensis strain 0331
Fig. 6 Western immunoblot analysis of purified rOMP28 fusion protein. Lane M, Precision Plus Protein All Blue Standards (Bio-Rad, USA); lane 1,
purified rOMP28 detected using His.Tag monoclonal antibody; lane 2, purified rOMP28 detected using S.Tag monoclonal antibody; lane 3, purified
rOMP28 detected using rabbit polyclonal antibodies against B. melitensis strain 0331
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rOMPs I-ELISA recorded 100 % sensitivity (45/45).
When sera from mice vaccinated with B. melitensis
Rev.1 vaccine strain was tested by rOMPs I-ELISA,
100 % specificity (45/45) was recorded. Additionally,
100 % specificity (45/45) was recorded when sera from
mice infected with Y. enterocolitica O:9 were tested by
rOMPs I-ELISA.
Discussion
In this study, rOMP25, rOMP28 and rOMP31 have been
successfully produced and used together to develop
rOMPs I-ELISA in a hope to increase the sensitivity of
the developed test for differential serodiagnosis of bru-
cellosis using mouse model. The isolation, cloning and
expression of B. melitensis strain 0331 omp25, omp28
Fig. 7 Western immunoblot analysis of purified rOMP31 fusion protein. Lane M, Precision Plus Protein All Blue Standards (Bio-Rad, USA); lane 1,
purified rOMP31 detected using His.Tag monoclonal antibody; lane 2, purified rOMP31 detected using S.Tag monoclonal antibody; lane 3, purified
rOMP31 detected using rabbit polyclonal antibodies against B. melitensis strain 0331
Fig. 8 Antibodies titer of mice sera using semi-quantitative RBPT. Group 1, mice infected with B. melitensis strain 0331; group 2, mice vaccinated
with B. melitensis Rev. 1 vaccine strain; group 3, mice infected with Y. enterocolitica O:9; (−ve) negative control, mice injected with PBS. ±SE at 95 % CI
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and omp31 genes were achieved using prokaryotic sys-
tem pET-32 Ek/LIC. Using BioEdit sequence alignment
editor software, the DNA sequencing results confirm
that omp25, omp28 and omp31 genes had correct orien-
tation, and they were in the open reading frame (ORF),
which in turn enable full amino acids translation of these
genes in the subsequent steps. The results of BLASTN
alignment showed that omp25 has 99 % identity with pub-
lished sequence of B. melitensis 16 M reference strain
which is due to the difference in nucleotide number 276,
which is C instead of T [18, 25]. In order to show whether
this nucleotide difference resulting in differences in the
amino acids sequence, the alignment of amino acids was
performed. The result showed that the nucleotide differ-
ence at number 276 in the omp25 did not cause any differ-
ences in the translation of the amino acid glycine (Gly).
While, the omp28 and omp31 obtained 100 % identity
with published sequence of B. melitensis 16 M reference
strain [16, 26] and [15, 20] respectively. Using amino acid
composition feature of BioEdit software, the predicted
molecular weight of the tagged fused proteins was esti-
mated to be 17 kDa. In addition, the amino acids of
omp25, omp28 and omp31 were also analyzed.
The SDS-PAGE analysis reveals the presence of pro-
tein bands of purified rOMP25, rOMP28 and rOMP31
with molecular weight of 42, 45 and 48 kDa respect-
ively. These sizes were agreed with the theoretically
molecular weights prediction of the expressed rOMP25,
rOMP28 and rOMP31 fusion proteins respectively. More-
over, the results of this study agreed with results obtained
by Letesson, et al. [21] and de Wergifosse, et al. [25] for
the rOMP25, and Gupta, et al. [27] and Seco-Mediavilla,
et al. [28] for the rOMP28, and Vizcaino, et al. [15] and
Gupta, et al. [20] for the rOMP31. Furthermore, Western
immunoblotting analysis revealed that the rOMP25,
rOMP28 and rOMP31 fusion proteins were detected by
His.Tag and S.Tag monoclonal antibodies. Additional con-
formation was made using rabbit polyclonal antibodies
against Brucella melitensis strain 0331 to assure the im-
munogenicity of the rOMP25, rOMP28 and rOMP31
fusion proteins, which in turn indicate that these re-
combinant fusion proteins were expressed in soluble
and active form.
The purified rOMP25, rOMP28 and rOMP31 were
combined together and named rOMPs. Therefore, mouse
model was used to determine the sensitivity and specificity
of rOMPs I-ELISA. Accordingly, three groups of mice
were set in this study. The first group was infected with B.
melitensis strain 0331 to demonstrate the antibody re-
sponse due to infection with B. melitensis field strain.
While the second group was injected with B. melitensis
Rev.1 vaccine strain, to demonstrate the antibody response
due to vaccination, and the third group was infected with
Y. enterocolitica O:9, to demonstrate cross reacting anti-
bodies. Antibodies in sera of all mice in the first and sec-
ond groups were detected using RBPT as early as 15 days
after infection, and peaked at 35–49 days, while the sera
from mice in the third group showed a much lower anti-
body reactivity using RBPT. According to OIE, the RBPT
is considered as reference test for serological diagnosis of
brucellosis. However, the inability to differentiate between
infected and vaccinated animals are the main problem fa-
cing RBPT because it is based on detection of antibody to
S-LPS that is immunodominant in the serological re-
sponses of both infected and vaccinated animals [4, 5]. Al-
though low antibodies titer was elicited in group 3, the
RBPT was able to detect cross reacting antibodies because
of smooth Brucella strains share common epitopes on the
O-PS with cross-reacting bacteria mainly Y. enterocolitica
O:9 [2, 9], and in less extent, the natural infection by a
Fig. 9 Percentage of positivity (PP) values of the sera from three groups of mice tested using in-house rOMPs I-ELISA. Group 1, mice infected with
B. melitensis strain 0331; group 2, mice vaccinated with B. melitensis Rev. 1 vaccine strain; group 3, mice infected with Y. enterocolitica O:9; (−ve)
negative control, mice injected with PBS. ±SE at 95 % CI
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number of other Gram negative bacteria can also produce
cross reacting antibodies, mainly, E. coli O:157 and Sal-
monella spp. [2, 8]. The results of rOMPs I-ELISA, testing
sera from three groups of mice, clearly indicated the pres-
ence of significant differences between group 1 and each
of group 2 and group 3, and this due to ability of rOMPs
I-ELISA to detect anti-OMP25, anti-OMP28 or anti-
OMP31 antibodies in mice infected with B. melitensis
strain 0331 rather than mice vaccinated with B. melitensis
Rev. 1 vaccine strain or infected with Y. enterocolitica O:9.
Earlier studies showed greater accessibility of OMP25
OMP28 and OMP31 epitopes to antibodies generated due
to infection with B. melitensis [19, 29]. However, previ-
ously developed ELISA based on single OMP was challen-
ging due to low sensitivity recorded, like rOMP28 (88.7 %)
[19] and rOMP31 (81.8 %) [20]. In our study, the rOMPs
I-ELISA recorded 100 % sensitivity (45/45), means that all
the mice infected with B. melitensis strain 0331 were
recognized as positive by our developed ELISA. Add-
itionally, the rOMPs I-ELISA recorded 100 % specificity
(45/45), means that all mice vaccinated with Rev. 1 vac-
cine strain or infected with Y. enterocolitica O:9 were
recognized as negative.
In summary, in this study, the developed rOMPs I-
ELISA was able to increase the sensitivity to detect the
infected animals. Moreover, it was also able to differenti-
ate the animals with FPSR. These findings suggesting
that rOMPs I-ELISA has potential diagnostic properties
which could be used as an effective tool in the differen-
tial serodiagnosis of brucellosis.
Conclusions
Combination of rOMP25, rOMP28 and rOMP31 to-
gether clearly increased the sensitivity of the developed
rOMPs I-ELISA. In addition, the results also indicated
that the rOMPs I-ELISA has the ability to detect specific
OMP antibodies due to infection with B. melitensis strain
0331 rather than vaccinal or cross reacting antibodies, and
this means it has the ability to differentiate between infec-
tion with B. melitensis and FPSR. However, these result re-
flect the strict controlled conditions of our study, further
evaluations should be performed which involves testing of
the developed rOMPs I-ELISA in sheep and goats, as real
hosts of B. melitensis, to achieve a definitive conclusion
about its usefulness in differentiation of FPSR in the sero-
logical diagnosis of brucellosis.
Methods
Bacterial stain and growth conditions
Brucella melitensis strain 0331 Malaysian isolate has
been used in this study as a source of the bacterial DNA
for cloning and expression of omp25, omp28 and omp31
genes. This isolate has been confirmed as B. melitensis
biovar 1 by Veterinary Laboratory Agency (VLA, Wey-
bridge, UK). Fresh colonies of B. melitensis strain 0331
were cultured in Brucella broth (BBL™, BD, USA) for
4 days at 37 °C with continuous shacking; the bacterial
cells were harvested by centrifuging.
PCR amplification and cloning
The DNA extraction and purification were performed
following the manufacturer instructions (Qiagen, USA).
Whereas, cloning was performed using pET-32 Ek/LIC
system (Novagen, USA). Based on published sequence of
B. melitensis 16 M reference strain [15, 16, 18], specific
sets of primers were designed (Table 1) and the omp25,
omp28 and omp31 genes were amplified using polymer-
ase chain reaction (PCR). The expected products have
extra 26 bp, represent vector cohesive overhangs (bold)
for efficient cloning with pET-32 Ek/LIC vector. After
amplification the produced insert was treated with LIC-
qualified T4 DNA Polymerase, and then, annealed to the
pET-32 Ek/LIC vector without the need for restriction
digestion or ligation. The resultant nicked, circular plas-
mids are named pET-32 Ek/LIC-omp25, pET-32 Ek/LIC-
omp28 and pET-32 Ek/LIC-omp31 transformed into
NovaBlue GigaSingles™ Escherichia coli competent cells
as initial cloning host. Positive inserts were screened by
direct colony PCR using the designed gene specific
primers and vector specific primers which includes T7
promoter and T7 terminator. Purified plasmid was sent
to First BASE laboratories, (Malaysia) for sequencing.
The obtained sequences were analyzed using The Basic
Local Alignment Search Tool (BLAST®) of the National
Center for Biotechnology Information (NCBI) database
and, BioEdit sequence alignment editor software, ver-
sion 7.0 [30].
Table 1 Primers used for amplification of B. melitensis omp25, omp28 and omp31 genes with vector cohesive overhangs (bold)
No Primer name Sequence (5′-3′) Length Expected product bp
1. B. melitensis omp25 F GACGACGACAAGATGCGCACTCTTAAGTCTCT 32 668
2. B. melitensis omp25 R GAGGAGAAGCCCGGTTAGAACTTGTAGCCGAT 32
3. B. melitensis omp28 F GACGACGACAAGATGAACACTCGTGCTAGCAATT 34 779
4. B. melitensis omp28 R GAGGAGAAGCCCGGTTACTTGATTTCAAAAACGA 34
5. B. melitensis omp31 F GACGACGACAAGATGAAATCCGTAATTTTGGCGT 34 749
6. B. melitensis omp31 R GAGGAGAAGCCCGGTTAGAACTTGTAGTTCAGAC 34
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Induction of expression and purification of recombinant
protein
The positive constructed recombinant clones were used
for transformation in expression prokaryotic host Escheri-
chia coli BL21(DE3) competent cells (Novagen, USA). Dir-
ect colony PCR screening was performed to verify the
positive clones using T7 promoter and T7 terminator pri-
mer sets. E. coli harboring pET-32 Ek/LIC-omp25, pET-32
Ek/LIC-omp28 and pET-32 Ek/LIC-omp31 plasmids were
grown in LB medium and the cells were induced by Over-
night Express™ Autoinduction System (Novagen, USA).
This system is designed for high-level protein expression
with pET expression system without the need to monitor
cell growth. To obtain the soluble fraction of the cells, the
protein extraction was performed using BugBuster® pro-
tein extraction kit with Benzonase® Nuclease (Novagen,
USA). Metal chelation chromatography based method was
used to purify the rOMP25, rOMP28 and rOMP31 using
Ni-NTA His-Bind® Purification Kit (Novagen, USA). The
uninduced cell lysate, induced cell lysate and purified
rOMPs were analyzed by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE).
Production of rabbit hyperimmune serum against Brucella
melitensis strain 0331
Two six months New Zealand white rabbits were used
for raising hyperimmune against B. melitensis strain
0331 according to the method of Cloeckaert, et al. [31].
Ethical approval letter, AUP No: 10R1 17/Feb 11-Jan 12
was obtained from Institutional Animal Care and Use
Committee (IACUC), Faculty of Veterinary Medicine,
Universiti Putra Malaysia, before starting the experi-
ment. The animals were housed under standard condi-
tions at the animal house facility having free access to
feed and water ad libitum.
The killed antigen was prepared by growing B. meli-
tensis 0331 in 100 ml of brucella broth (BBL™, UK) for
3 days at 37 °C using incubator shaker. The broth was
pelleted down and the cells were washed in phosphate
buffer saline (PBS). Afer that the cells were killed by
heating and adjusted to concentration of 109 organism/
ml in PBS containing 0.5 % phenol by optical density
measurment at 600 nm in a spectrophotometer (eppen-
dorf Biophotometer plus).
The rabbites were injected subcutanously (s.c.) with B.
melitensis 0331 (killed antigen) 1 × 109 colony forming
units (cfu)/ml with Freund’s complete adjuvant (FCA)
(Merck, Germany), followed by s.c. injection of two
booster doses of B. melitensis (killed antigen) 0.5 ×
109 cfu/ml with Freund’s incomplete adjuvant (FIA)
(Merck, Germany) at days 21 and 35 respectively and
the third booster dose was performed at day 45 by s.c.
injection of B. melitensis (killed antigen) 0.5 × 109 cfu/ml
with out any adjuvant. Blood samples were collected
from ear vein under sedation at day 0 as self control, to
reduce the number of animals included in the study, and
subsequently every 2 weeks interval to assess the im-
mune response of the rabbits. The hyperimmune serum
against B. melitensis was collected by cardiac puncture
under anesthesia on day 56. Once the required blood
volume was collected, the rabbit was euthanized while
still deeply anesthetized. The collected serum was stored
at −20 °C until used.
Western Immunoblotting assay
The expressed rOMP25, rOMP28 and rOMP31 were
confirmed to be soluble fusion protein by Western im-
munoblotting using His.Tag and S.Tag HRP conjugated
monoclonal antibodies (Novagen, USA). In addition,
rabbit polyclonal antibodies against Brucella melitensis
strain 0331 was also used to confirm the results. Each
purified rOMP was transferred from the unstained poly-
acrylamide gel onto 0.45 μm nitrocellulose membrane
(Bio-Rad, USA) according to the standard procedure by
Towbin, et al. [32]. Each blotted membrane which repre-
sents one of the rOMP was cut into three membrane
parts and blocked using 1 % casein-TBST (Novagen,
USA). After washing with TBST, the first membrane part
was incubated with a dilution of 1:1500 of His-protein
HRP conjugated monoclonal antibody. While the second
membrane part was incubated with a dilution of 1:5000
of S-protein HRP conjugated monoclonal antibody. After
washing, the colorimetric detection was carried out using
TMB peroxidase substrate (Calbiochem, USA) until the
color developed. The reaction was stopped by rinsing the
membrane in deionized water. The third membrane part
was incubated with 1:500 dilution of rabbit hyperimmune
serum for 2 h and goat anti rabbit HRP conjugate (KPL,
USA) was used as secondary antibody with 1:3000 dilution
for 1 h. The remaining washing and colorimetric detection
steps were the same as stated for His.Tag and S. Tag.
Mouse model for evaluation of rOMP25, rOMP28 and
rOMP31
Total of (165) five-week-old female BALB/c mice were
obtained from the animal facility, Faculty of Veterinary
Medicine, Universiti Putra Malaysia (UPM). Ethical ap-
proval letter, AUP No: 10R117/Feb 11-Jan 12 was ob-
tained from IACUC, Faculty of Veterinary Medicine,
Universiti Putra Malaysia, before starting the experi-
ment. The mice were randomly distributed into three
groups of 55 mice and housed in separated plastic cages
in controlled animal house facilities for one week to ac-
climate their environment. The mice were provided with
food and water ad libitum.
Following the procedure of Jimenez de Bagues, et al.
[33], 45 mice in group 1 were infected intraperitoneally
(i.p.) with 5 × 104 cfu of B. melitensis strain 0331 and 45
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mice in group 2 were injected s.c. with B. melitensis Rev.
1 vaccine strain 5 × 105 cfu (CZveterinaria, Spain). While
in group 3, 45 mice were infected i.p. with Y. enterocoli-
tica O:9 3 × 104 cfu [34]. Additionally, for each of the
three groups, five mice were sampled pre-infection and
five mice were injected with PBS as negative control. Using
cardiac puncture technique under general anesthesia, five
serum samples were collected from the mice in each group
every seven days interval starting at day seven to day
63. The negative controls were sampled at day 63. Once
the required blood volume is collected, the mouse was
euthanized while still deeply anesthetized using cervical
dislocation to produce rapid euthanasia. Sera samples
were stored at −20 °C until used.
Rose Bengal plate test
Sera samples collected from three groups of mice
during the experiment period (0–63 days), in addition
to negative control samples were tested using semi-
quantitative RBPT as described by OIE [35] with some
modifications. Briefly, isotonic saline solution was used
to prepare serial dilutions of the mice sera (1/2, 1/4, 1/
8, 1/16, 1/32, 1/64, 1/128), then equal volume of the
diluted seum and RBPT antigen have been mixed and
the results was read within 4 min for any positive
agglutination. The titer can be calculated by multiply-
ing the dilution factor by the detection limit 25, to
give the IU/ml concentration. The RBPT antigen and
control sera were obtained from Veterinary Laboratory
Agency (VLA, Weybridge, UK).
Recombinant OMPs I-ELISA
Sera obtained from the three groups of mice were
analyzed by rOMPs I-ELISA. The rOMPs coating
antigen was produced by combination of equal con-
centrations of rOMP25, rOMP28 and rOMP31 and
used as one coating antigen. The wells of polystyrene
plates (Maxisorp, Nunc, Denmark) were coated with
100 μl of purified rOMPs at final concentration of
0.39 μg/ml in 0.05 M bicarbonate buffer (pH 9.6) and
incubated overnight at 4 °C. This concentration was
determined by checkerboard titration to reach optimal
working conditions of sensitivity and specificity fol-
lowing the procedure discribed by Crowther [36]. The
wells were emptied and washed three times with
phosphate buffer saline-Tween20 (PBST) and then
blocked with 5 % skim milk (oxoid, UK). Following
incubation 100 μl of mice sera samples, positive and
negative control sera diluted 1:200 were added into
the plates in duplicate wells and incubated at 37 °C
for 1 h. After washing with PBST for three times the
plates were incubated with 1:5000 goat anti mouse
HRPO IgG (H + L conjugate) (KPL, USA) for 1 h at 37 °
C. After washing with PBST, the wells were filled with
substrate solution containing TMB (3,3′,5,5′-tetra-
methyl benzidine) (KPL, USA). Finally, color develop-
ment was stopped by adding 1 N HCL, after 10 min of
incubation of the plates in dark at room temperature.
The optical density was measured at 450 nm wavelength
using an ELISA reader (Bio-Rad, USA).
Statistical analysis
IBM SPSS Statistics 19 software (IBM Corp., Armonk,
NY, USA) was used for statistical analysis. Differences in
antibody titers expressed in IU/ml among the three
groups using semi-quantitative RBPT were estimated by
comparing the means using one-way ANOVA, and a P
value < 0.05 was considered statistically significant at
95 % confidence interval (CI). The percentage of positiv-
ity (PP) value was calculated as described in the follow-
ing equation.
PP ¼ test sample ODð Þ − negative control sera ODð Þ
positive control sera ODð Þ − blank ODð Þ  100
The PP values were statistically analyzed using on-
way ANOVA, Tukey’s multiple comparison test, to
detect any significant differences among three groups
of mice and a P value < 0.05 was considered statisti-
cally significant at 95 % CI. The receiver operating
characteristics (ROC) was used in order to determine
the cut-off value of the trade off between sensitivity
and specificity of rOMPs I-ELISA using mice sera
from group 1 and 2 including negative controls and
the sensitivity and specificity of rOMPs I-ELISA were
estimated accordingly [36].
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